For instance, the small molecule inhibitor TLK199 has shown promise in sensitizing cancer cells to chemotherapy by selectively targeting GSTP1, improving the efficacy of drugs like cisplatin in ovarian cancer models (Lv et al. 2023). The gene discussed is GSTP1; the disease is cancer.